Geomega Targets November Start-Up for Its Magnet-Recycling Demonstration Plant

Geomega Resources is nearing the point where its rare-earth recycling story stops being mainly an engineering project and starts being a commercial test. The Montreal-based company said on September 2 that construction of its NdFeB magnet-recycling demonstration plant is in its final installation phase, with more than 75% of process piping complete and commissioning expected to begin in November.

For a company that has spent years developing hydrometallurgical recycling technology, that is a meaningful milestone. But it also shifts the investment question. The critical issue is no longer whether Geomega can build the demonstration circuit. It is whether the plant can secure enough magnet scrap, run consistently, produce saleable separated oxides and convert active commercial discussions into contracts.

Geomega says it is already discussing feed supply, rare-earth oxide offtake, toll processing and potential technology licensing. Those talks are strategically important because the demonstration plant is not designed as a mine-dependent project. Its economics depend on access to end-of-life magnets and manufacturing scrap containing neodymium, praseodymium, dysprosium and terbium, then recovering those materials at sufficient yield and purity to compete with virgin supply.

The facility has been described by Quebec as capable of producing about 150 tonnes a year of rare-earth oxides, while earlier company disclosures described a feed throughput of about 1.5 tonnes per day. Those two figures measure different points in the process, but together they show the scale of the next step: large enough to generate commercial data, still far below the scale of the global magnet market.

Government support has materially reduced the capital burden. Quebec awarded Geomega C$3 million through Technoclimat for the demonstration plant. Natural Resources Canada separately committed C$3 million under the Critical Minerals Research, Development and Demonstration program, and NGen awarded another C$2.04 million toward magnet recycling and rare-earth oxide production. The federal CMRDD project page now lists the Geomega project as expected to be completed by 2027, underscoring that November commissioning is the start of validation rather than the end of commercialization.

The balance sheet makes that distinction important. At February 28, Geomega reported C$2.43 million of cash and cash equivalents, C$2.06 million of tax credits and government grants receivable, and C$4.62 million of total liabilities. During the first nine months of fiscal 2026, option and warrant exercises brought in about C$3.52 million of gross cash. The company also secured a C$750,000 interest-free repayable contribution from Canada Economic Development for Quebec Regions for expanded laboratory and piloting infrastructure.

That funding profile is constructive, but it also shows why the commercial ramp matters. Geomega has relied on grants, concessional support and equity-linked financing while building out its technology platform. A demonstration plant that reaches stable operation and generates contracted feed or toll-processing revenue could begin to change the quality of that funding mix. A slow commissioning cycle or delays in customer qualification would keep the company dependent on external capital for longer.

The process itself has a credible technical rationale. Geomega says its closed-loop reagent system can recover and reuse up to 95% of reagents, including hydrochloric acid, while reducing effluent and reagent costs. Earlier independent reporting on the process described recovery of neodymium, praseodymium, terbium and dysprosium from shredded permanent magnets and production of rare-earth oxides at high purity. The demonstration plant is intended to prove that performance on a continuous, industrially relevant basis rather than in batch and pilot campaigns.

Geomega is also trying to widen the value of its platform beyond magnets. In the September update, the company said its bauxite-residue program had processed 12 samples from eight alumina refineries and produced titanium dioxide at greater than 98% purity along with a rare-earth and scandium concentrate at about 90% purity. It has also restarted and expanded sulphide-tailings work using material supplied by global mining companies.

Those additional programs create optionality, but they should not distract from the near-term catalyst. The magnet-recycling plant is the asset closest to commercial validation, and it is where the company has already attracted substantial public funding. Success there would provide a reference case for licensing the chemistry elsewhere. Failure to achieve reliable throughput, recoveries or product quality would make the broader technology platform harder to finance.

The competitive backdrop is also getting tougher. Western governments are spending heavily to build non-Chinese rare-earth supply chains, and recycling is increasingly treated as a strategic source of magnet feed. That creates policy support for Geomega, but it also means the company is not alone. Larger miners, magnet producers and recycling groups are advancing their own closed-loop systems, often with stronger balance sheets and pre-existing customer networks.

That makes feedstock contracting the first commercial hurdle. A recycling plant without reliable scrap supply can be technically successful and still underutilized. Geomega’s discussions around feed, tolling and offtake therefore matter as much as the November start-up date. Investors should look for multi-year supply agreements, customer qualification milestones, oxide specifications, recovery data and evidence that the plant can operate for sustained campaigns rather than short demonstration runs.

The next catalyst is straightforward: completion of piping and insulation through the fall, followed by process-equipment commissioning in November. After that, the more consequential milestones will be stable throughput, disclosed recovery and purity performance, and signed commercial agreements. Geomega has largely funded the engineering risk. It now has to prove that the chemistry can support a business.